ReviewBioresources and bioprocessing2026
Engineered microorganisms unlock a new era of diterpenoid biomanufacturing: recent advances and future perspectives.
Review in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diterpenoids are natural compounds composed of four isoprene units. They possess diverse biological activities and widespread applications in the cosmetics, food additives and pharmaceutical. With the rapid advancement of synthetic biology, the biomanufacturing of diterpenoids via microbial metabolism has witnessed substantial advancements. Microbial chassis such as Escherichia coli, Saccharomyces cerevisiae, Yarrowia lipolytica and Rhodosporidium toruloides, have been successfully engineered to enable efficient biosynthesis of these compounds, thereby demonstrating substantial potential for industrial-scale applications. In this review, the construction of diterpenoid biosynthetic pathways in microbial cell factories is summarized. The research progress and engineering strategies for efficient microbial synthesis of diterpenoids are discussed, and the key challenges and future directions facilitating the design of high-yield diterpenoid production platforms and their translation into industrial practice are explored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.